Author

Tomofumi Saka

Institution: Gifu Pharmaceutical University

Observed institution: Gifu Pharmaceutical University

ORCID: 0009-0000-6332-7965

Observed ORCID: 0009-0000-6332-7965

OpenAlex ID: A5080979037

Antiandrogenic Effects of a Polyphenol in Carex kobomugi through Inhibition of Androgen Synthetic Pathway and Downregulation of Androgen Receptor in Prostate Cancer Cell Lines

2022 · Yudai Kudo, Satoshi Endo, et al. · International Journal of Molecular Sciences · 12

Inhibition of autophagy by Atg7 knockdown enhances chemosensitivity in gemcitabine/paclitaxel-resistant pancreatic cancer MIAPaCa2 cells

2025 · Yudai Kudo, Kotaro Hirota, et al. · The Journal of Biochemistry · 6

Kobochromone A, a polyphenol in Carex kobomugi, suppresses androgen signaling induced by 11-oxygenated androgens and enhances the efficacy of AKT inhibitors in triple-negative breast cancer cells

2025 · Masatoshi Tanio, Yuri Miyamoto, et al. · Steroids · 5

Gnetin C sensitizes darolutamide-resistant prostate cancer cells by targeting NAD+ and energy metabolism

2025 · Mina Kawai, Tomofumi Saka, et al. · Biochemical and Biophysical Research Communications · 3

β-Nicotinamide mononucleotide prevents senescence and lipid accumulation in hepatic stellate cells by restoring SIRT1 function

2026 · Tomofumi Saka, Riri Hayashi, et al. · Chemico-Biological Interactions · 2

Upamostat potentiates bortezomib cytotoxicity and delays proteasome recovery in bortezomib-resistant malignant lymphoma cells through modulation of the DDI2/NRF1 axis

2026 · Atsumi Ota, Sota Maruyama, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Enhanced NRF1-mediated proteasome bounce-back and nelfinavir-mediated bortezomib sensitization in gemcitabine/cisplatin-resistant bladder cancer cells

2026 · Atsumi Ota, Mina Kawai, et al. · Biochemical and Biophysical Research Communications

Synthesis of potent human DHRS11 inhibitors and their efficacy against androgen-dependent proliferation and sensitivity to AKT inhibitor Capivasertib of triple-negative breast cancer cells

2026 · Yuri Miyamoto, Wakana Hirai, et al. · European Journal of Medicinal Chemistry

Works count: 8

Citation count: 28

H-index: 3

I10-index: 1